Cristiane Bergerot: Exciting findings from ASCO24 by Nazli Dizman et al.

Cristiane Bergerot shared a post on X:

“Exciting findings from ASCO24: CBM588, a Clostridium butyricum-based biotherapeutic, corrects gut dysbiosis and enhances clinical outcomes in mRCC patients receiving ICI combinations.

Promising results pave the way for a phase III study.”

Source: Cristiane Bergerot/X

Cristiane Bergerot is the Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital in Brasilia, Brazil. She has been working with cancer patients for almost 15 years as a clinician and as a researcher.

She has over 30 peer-reviewed publications in journals including first-author publications in Cancer, Journal of Immunotherapy for Cancer, British Journal of Urology International and Pscyhooncology.

She has received four merit awards from the American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation and was selected for the SWOG Young Investigator Course.